Triplixam 5Mg/1.25Mg/5Mg 30 tablets: is indicated as substitution therapy for treatment of essential hypertension, in patients already controlled with perindopril (Triplixam 5Mg/1.25Mg/5Mg)/Indapamide (Triplixam 5Mg/1.25Mg/5Mg) Fixed dose combination and Amlodipine (Triplixam 5Mg/1.25Mg/5Mg), taken at the same dose level.